Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 billion: WSJ

Business

FILE PHOTO: Switzerland’s national flag flies in front of the logo of Swiss drugmaker Novartis in Basel, Switzerland, January 30, 2019. REUTERS/Arnd Wiegmann/File Photo

(Reuters) – Swiss drugmaker Novartis AG (NOVN.S) is nearing an agreement to acquire U.S. biotechnology firm The Medicines Co (MDCO.O) for about $7 billion, the Wall Street Journal reported on Saturday.

The deal, in which Novartis has agreed to pay $85 a share, could be announced this weekend, the Journal reported, citing people familiar with the matter.

Neither Novartis nor The Medicines Co were immediately available for comment on Saturday.

Reporting by Kanishka Singh in Bengaluru; editing by Jonathan Oatis

Products You May Like

Articles You May Like

An Offer You Can’t Refuse, The Godfather 4K And Digital Is Half Off For Black Friday
Manchester United owners confirm they could sell the club
Primark to open four new stores and create 850 jobs
EVERYDAY CARRY: Odyssey
Energy firms accused of ‘failings across the board’ ahead of ‘very challenging winter’

Leave a Reply

Your email address will not be published.